DX-88 (ecallantide)

ecallantide · Shire

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DX-88 (ecallantide), covering 2010-05-04 to 2010-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) [Phase 3]